Dr. Fatimah Qassadi | Prince Sattam Bin Abdulaziz Univeristy | Saudi Arabia
Dr. Fatimah Ibrahim Qassadi is a dedicated pharmacist, academic, and researcher with extensive experience in both clinical and educational settings across Saudi Arabia and the United Kingdom. With over four years of clinical practice at King Abdulaziz Medical City—one of Riyadh’s leading governmental hospitals—she has developed strong expertise in clinical pharmacy, medication safety, pharmacotherapy, and patient-centred care. She currently serves as a Lecturer at Prince Sattam bin Abdulaziz University (PSAU), where she previously worked as a teaching assistant. She also held an academic role at the University of Nottingham, School of Pharmacy, contributing to undergraduate teaching, supervision, and practical training. Dr. Qassadi holds a PhD in Pharmacy from the University of Nottingham, an MSc in Medicinal Natural Products and Phytochemistry (Distinction) from University College London, and a First-Class Honours Bachelor of Pharmacy from King Saud University. Her research focuses on gastrointestinal bacteria, faecal microbiota transplantation (FMT), and plant-derived therapeutics, with publications in reputable journals such as Pathogens, Frontiers in Nutrition, and Gut. She has presented her work at major international conferences and received multiple awards for best scientific presentations in the UK and China. Her competencies span curriculum development, instructional design, scientific research, statistical analysis (SPSS, MATLAB), and academic leadership. She is certified in Good Clinical Practice (GCP), Lean Six Sigma, project management, advanced MATLAB, and higher education teaching. She is also licensed as a pharmacist in Saudi Arabia and trained in essential healthcare safety practices, including BLS and CPR. Actively engaged in community initiatives, Dr. Qassadi has contributed to health awareness campaigns, scientific committees, and student mentorship programs. Passionate about advancing pharmacy education and healthcare quality, she is committed to supporting Saudi Vision 2030 through innovative teaching, impactful research, and the development of future pharmacy professionals.
Featured Publications
Qassadi, F. I., Johnson, C., Robinson, K., Griffin, R., Polytarchou, C., Kao, D., Kim, D.-H., Griffiths, R. L., Zhu, Z., & Monaghan, T. M. (2025). Untargeted metabolomics identifies faecal filtrate-derived metabolites that disrupt Clostridioides difficile metabolism and confer gut barrier cytoprotection. International Journal of Molecular Sciences, 26(22), Article 11221. https://doi.org/10.3390/ijms262211221
Sun, Y., Liu, S., Chen, L., Zhou, Z., Ma, M., Li, J., Lu, Y., Shi, Y., Yao, T., Feng, R., … Qassadi, F. I. (2025). Spaceflight redefines ageing-associated microbiota. iMeta. https://doi.org/10.1002/imt2.70023
Qassadi, F., Kim, D.-H., Griffiths, R., Kao, D., Zhu, Z., & Monaghan, T. (2024). P102: Dissecting the metabolic impact of faecal microbiota transplantation (FMT) in C. difficile and E. coli infections using 3D OrbiSIMS. Oral Presentations, Gut, 73(Suppl. 2), A111. https://doi.org/10.1136/gutjnl-2024-bsg.184
Qassadi, F., Monaghan, T., Kim, D.-H., Griffiths, R., & Zhu, Z. (2023). Antibacterial evaluation of natural oridonin and its chemically synthesised derivatives. Planta Medica, 89(11), 1003–1013. https://doi.org/10.1055/s-0043-1774023
Qassadi, F. I., Zhu, Z., & Monaghan, T. M. (2023). Plant-derived products with therapeutic potential against gastrointestinal bacteria. Pathogens, 12(2), 333. https://doi.org/10.3390/pathogens12020333
Surendran, S., Qassadi, F., Surendran, G., Lilley, D., & Heinrich, M. (2021). Myrcene—What are the potential health benefits of this flavouring and aroma agent? Frontiers in Nutrition, 8, 699666. https://doi.org/10.3389/fnut.2021.699666